🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsStructure-activity relationships of GLP-1 analogs — anyone have experience? Page 3

Structure-activity relationships of GLP-1 analogs — anyone have experience?

sarah_TO Sun, Aug 4, 2024 at 10:31 PM 32 replies 1,968 viewsPage 3 of 7
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Aug 5, 2024 at 2:46 AM#11
NurseKim_ATL said:
Structure-activity relationships of is not that straightforward in my experience

This is exactly right. NurseKim_ATL articulated what I have been trying to explain to my doctor for months. The Structure-activity aspect is the most important factor.

13 1pete_nash, hank_denver, carlos_SATX and 10 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Aug 5, 2024 at 3:03 AM#12

Reading this thread on Structure-activity hits close to home. Night shift nurse — I started at 263 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 38 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Structure-activity — take the leap. It was the best health decision I have ever made. ❤️

17 11julia.endo, JessicaM_2024, TomFromTexas and 14 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Aug 5, 2024 at 3:20 AM#13

KevinCompounds — that is really helpful context on Structure-activity. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

1 13KetoKyle
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Aug 5, 2024 at 3:37 AM#14

To answer MeganSA_TX's question specifically:

From a clinical standpoint, Structure-activity is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

38 7chris_chi24, tampaLisa73, KarenAZ_mom and 35 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Aug 5, 2024 at 3:54 AM#15

Bookmarked 📌 The Structure-activity info in this thread is essential. Coming back to this for sure.

32 21SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 29 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register